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Summary 
 
Background 
 
Primary care data is the single richest source of routine health care data. However its use, 
both in research and clinical work, often requires data from multiple clinical sites, clinical 
trials databases and registries. Data integration and interoperability are therefore of 
utmost importance. 
 
Objectives 
 
TRANSFoRm’s general approach relies on a unified interoperability framework, 
described in a previous paper. We developed a core ontology for an interoperability 
framework based on data mediation. This article presents how such an ontology, the 
Clinical Data Integration Model (CDIM), can be designed to support, in conjunction with 
appropriate terminologies, biomedical data federation within TRANSFoRm, an EU FP7 
project that aims to develop the digital infrastructure for a learning healthcare system in 
European Primary Care. 
 
Methods 
 
TRANSFoRm utilizes a unified structural/terminological interoperability framework, 
based on the local-as-view mediation paradigm. Such an approach mandates the global 
information model to describe the domain of interest independently of the data sources to 
be explored. Following a requirement analysis process, no ontology focusing on primary 
care research was identified and, thus we designed a realist ontology based on Basic 
Formal Ontology to support our framework in collaboration with various terminologies 
used in primary care. 
 
Results 
 
The resulting ontology has 549 classes and 82 object properties and is used to support 
data integration for TRANSFoRm’s use cases. Concepts identified by researchers were 
successfully expressed in queries using CDIM and pertinent terminologies. As an 
example, we illustrate how, in TRANSFoRm, the Query Formulation Workbench can 
capture eligibility criteria in a computable representation, which is based on CDIM. 
 
Conclusion 
 
A unified mediation approach to semantic interoperability provides a flexible and 
extensible framework for all types of interaction between health record systems and 
research systems. CDIM, as core ontology of such an approach, enables simplicity and 
consistency of design across the heterogeneous software landscape and can support the 
specific needs of EHR-driven phenotyping research using primary care data. 
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Introduction 
 
Primary care data is the single richest source of routinely collected health care data. 
However its use, both in research and clinical work, often requires data from multiple 
clinical sites with different health record systems and integration with clinical trial and 
other types of medical data.[1] Data interoperability is therefore of utmost importance, 
and is typically implemented using a set of models and mappings.[2] There have been 
attempts to create generic information models to serve as standards, including the 
OpenEHR reference model, the HL7 Reference Information Model (RIM) and the 
Clinical Data Acquisition Standards Harmonization (CDASH) model.[3–7] An ongoing 
international collaboration between standards organizations and industry partners, the 
Clinical Information Modeling Initiative (CIMI), aims at bringing together a variety of 
approaches to clinical data modeling (HL7 templates, openEHR archetypes, etc.) as a 
series of underlying reference models.[8] Nevertheless, many existing data sources are 
not designed according to these initiatives.[9] 
 
TRANSFoRm is an EU FP7 project that aims to comprehensively support the integration 
of clinical and translational research data in the primary care domain as part of a learning 
healthcare system.[10,11] Its vision is demonstrated through three use cases: a genotype-
phenotype around type 2 diabetes, a randomized clinical trial of treatment for 
gastroesophageal reflux disease and a diagnostic decision support system. It relies on 
software tools, such as a Query Formulation Workbench, a Study Manager and a 
Decision Support Ontological Evidence Service. They all need to access heterogeneous 
data sources. Moreover, the last two require the possibility of returning collected data 
back to the electronic health record (EHR) system. To that goal, the Clinical Data 
Integration Model (CDIM) was designed as the integration cornerstone for the project to 
enable interoperability between different types of data sources and different countries. 
 
The mediation approach employed by CDIM allows structurally heterogeneous local 
sources to be used in distributed infrastructures.[12] A central information model is 
related to each local model via mappings. Queries are first expressed according to the 
central model and then “translated” by the system for each local source. Each source 
therefore retains its structure and control over its data. BIRN, caBIG and Advancing 
Clinico-Genomic Trials piloted this approach in the biomedical domain.[13–15] CDIM is 
the first mediation approach for primary care research. 
 
Other approaches have been explored. One strategy relies on creation and maintenance of 
a data warehouse, to which data from each local data source is transferred. If the local 
source does not share the structure of the data warehouse, an Extract-Transform-Load 
(ETL) process is used to transfer and transform the data into the target structure. The i2b2 
initiative is an example of such an approach.[16] A uniform and unique structure can then 
be used for queries. When local sources share a similar structure, data federation can be 
used, whereby instead of transferring data, queries are executed locally at source and the 
results aggregated. The ePCRN project explored this approach for primary care research, 
by ensuring the structure of all its sources conforms to the American Society for Testing 
and Materials Continuity of Care Record (CCR) information model.[17,18] The Shared 
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Health Research Information Network (SHRINE) uses a similar approach to federate 
i2b2 sources.[19] However, since TRANSFoRm has no control over the data sources’ 
structure and since sources will not allow TRANSFoRm to use ETL, these approaches 
could not meet our requirements. 
 
Objectives 
 
TRANSFoRm’s general approach relies on a unified interoperability framework, 
described in a previous paper.[20] We developed a core ontology for an interoperability 
framework based on data mediation. This article presents how such an ontology, the 
Clinical Data Integration Model, can be designed to support, in conjunction with 
appropriate terminologies, biomedical data federation within TRANSFoRm, an EU FP7 
project that aims to develop the digital infrastructure for a learning healthcare system in 
European Primary Care. 
 
Methods 
 
The Clinical Data Integration Model (CDIM) was designed to represent clinical elements 
relevant to primary care and serve as a basis for data integration in the TRANSFoRm 
project. Data integration often relies on a combination of two types of models: 
information models (also called structural models) and terminological models (also 
referred to as semantic models). These two types of models, structural and 
terminological, are not independent as there are mutual constraints between the 
information models and coding systems[21] requiring these two models to be bound in 
order to fully assert their content.[22] 
 
For example, a field in a database might be named dx and contain the value T90. By 
binding the information model, where dx represents a patient diagnosis, with the 
terminological model used, the International Classification of Primary Care 2 (ICPC-2), 
we can assert that this represents a diagnosis of non-insulin dependent diabetes.[23,24] 
The equivalent representation using CDIM is achieved by binding the class diagnosis 
(OGMS_0000073)a with the term T90 from ICPC-2. 
 
TRANSFoRm utilizes a unified structural/terminological interoperability framework, 
based on the local-as-view paradigm bringing together information models, terminologies 
and binding information, as shown in Figure 1.[20] The generic data queries expressed 
with CDIM are mapped to the local Data Source Model (DSM), so that they can be 
executed. Such an approach mandates the global information model to describe the 
domain of interest, independently of the data sources to be explored. Figure 2 illustrates 
how the different models can interact together, through an example using the  General 
Practice Research Database (GPRD) and the NIVEL Primary Care Database (NPCD) as 
data sources.[25,26] 
                                                            
a Throughout the text, ontology classes and properties will be italicized with RDF identifiers presented in 
parentheses. Here, the class diagnosis bears the rdf:id OGMS_0000073 since the class is imported in CDIM 
from the Ontology of General Medical Science. 
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Figure 1: Interoperability framework based on CDIM in context of the Query 
Formulation Workbench. CDIM and terminologies are bound together to express queries 
independently of specific sources. Data source models (DSM), CDIM to DSM mappings 
and terminology mappings are used to translate the query during the mediation stage in 
order to execute it on local sources and provide unified results. 
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Figure 2: Model interactions in the task of retrieving a list of patient identifiers and 
diagnoses. In the GPRD database, the “medcode” field contains a diagnosis only if the 
field “constype” is equal to 3 for the same record. (DSM: GPRD and NPCD; blue boxes 
– CDIM classes, grey boxes – terminological mappings). 
 
Both types of models are required (information and terminological) since they each carry 
unique types of information. Terminologies express generic concepts of disease or state 
without implying the clinical context in which the data is created or used.[27,28] The 
same concept can be used to represent a possible diagnosis, a confirmed diagnosis, or a 
comorbidity. It may also be used in the history section of a patient record to represent a 
problem that occurred years before or even in the patient’s family. Moreover, a 
terminology like the International Classification of Disease 10 (ICD 10) is meant to be 
used by various systems (e.g., public health surveillance, electronic health records, billing 
systems).[29,30] 
 
On the other hand, information models usually focus on high level concepts (e.g., 
diagnosis) and omit particular representations of data (e.g., adenocarcinoma of the 
prostate), in order to be flexible and support binding with multiple terminologies, which 
might vary in depth and coverage. Furthermore, they provide the structure that is used to 
organize patient data in health records and databases (structural models). 
 
Nevertheless, there is a grey zone where certain concepts might be found both in 
information models and terminologies. For example, should an information model 
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contain concepts like Type 1 diabetes mellitus and Type 2 diabetes mellitus?  Or, should it 
only contain the concept diagnosis, and rely on terminologies to support the relationships 
between these two diabetes concepts, as they can also be found in ICD-10-CM for 
example (codes E10 and E11)? This underlines the importance of recognizing that 
information models and terminologies are not discrete entities, but rather a continuum 
along which the appropriate abstractions are constructed. 
 
When developing CDIM, if some information was to be found in a recognized 
terminology (e.g., diabetes concepts are present in the ICPC-2 and ICD-10-CM), then 
only the “parent” concept was included in CDIM (e.g., Disease). However, exceptions 
were occasionally made for efficiency purposes, when a concept would frequently appear 
in queries. Taking blood pressure as an example, a systolic blood pressure measurement 
of 100 mmHg could be expressed with two triplets, linked together:  
 physical examination = systolic blood pressure measurement 
 measurement datum = 100 mmHg. 
Yet, if included in CDIM, its expression only requires the assignments: 
 systolic blood pressure measurement datum = 100 mmHg.  
Given the extensive use of such measurements, including it in CDIM simplifies query 
construction. 
 
Content Development 
 
The specific requirements for primary care data were first gathered through discussions 
with experts in the field, as well as, through a sampling of various research criteria in 
order to get a broad view of the domain.[31] The continuum of primary care aims at 
following the patients from birth to death, including disease treatment and preventive 
care. As opposed to specialist care, primary care data tend to include longer follow-up 
time and a broader view of the patient, but with less detailed information. The primary 
care patient population reflects all degrees of disease severity and co-morbidity compared 
to disease specific records where sub-populations are followed. The particular nature of 
primary care data makes it especially well-suited to support “real-world” evaluations or 
to study care trajectories for example.[32]    
 
Although many clinical concepts such as diagnosis, medication or demographics are not 
unique to primary care, two are specifically important in primary care: reason for health 
care encounter and health care episode. The former captures the fact that patients often 
seek medical attention because of a sign or symptom that may or may not eventually lead 
to an established diagnosis. Within CDIM, Reason for health care encounter is 
represented as a role, in order to enable both symptoms and diseases to be qualified as the 
main reason for the visit.[33] For example abdominal pain would have the role reason 
for health care encounter role during the initial visit, and Crohn’s disease or pancreatitis 
could hold this role in subsequent encounters. 
 
The health care episode (often referred to as “episode of care”) is introduced to take into 
account the fact that patients will often see their primary care physician for longitudinal 
follow-up. As a result, although multiple encounters might be coded with a diagnosis of 
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major depression, they might all be related to the same major depression. Furthermore, 
the diagnostic problem may evolve during an episode of care as new information is 
gathered. Recognizing this is crucial to proper assessment of incidence and related 
measures.[34] CDIM captures this semantic using the class health care episode, with the 
axiom “health care episode has_part some health care encounter”. A single encounter 
can then also be part of multiple health care episodes as multiple problems can be 
addressed during one visit. 
 
In order to address the integrative requirements of primary care data, CDIM also contains 
organizational concepts, such as physical practices. In TRANSFoRm, this allows CDIM 
queries to refer to a specific set of practices as selected by the researcher. Supporting 
organizational units in CDIM also allows a more finely grained control over data access 
security, as policies can be applied distinctly to different subsets of data. 
 
Genetic technology is rapidly evolving and the availability of genetic data is increasing, 
introducing new research questions and paradigms. Masys et al consider requirements for 
levels of integration of genomic data into Electronic Health Records.[35] Following this 
approach, CDIM supports interpretive codes which can be readily used for automated 
processes for single nucleotide polymorphisms (SNP), but not the full sequence 
information. 
 
Ontology 
 
CDIM supports the unification of structural, terminological and binding information. 
Traditionally, these models have been dealt with separately but they are interdependent 
and share requirements.[21] In order to address this interdependence and facilitate the 
framework’s design and deployment, a decision was made to bring them together within 
one structure, and to rely on Mayo Clinic’s LexEVS open-source terminology server as 
the storage solution, given its versatility and ability to handle multiple custom models, 
including ontologies.[36]  
 
As a mediation schema, CDIM needs to support data integration from multiple types of 
data sources. Current data sources used in TRANSFoRm include relational and XML 
databases, both standards based, such as HL7 CDA and non-standard ones, so the current 
interoperability framework is designed to support this.[37]  
 
Two general approaches exist in terms of formal ontologies: the realist and the cognitivist 
approaches. A cognitivist ontology aims at formalizing the concepts we use to categorize 
the world, as revealed by our common sense and our language: such an ontology has a 
cognitive and linguistic bias. For example, the Descriptive Ontology for Linguistic and 
Cognitive Engineering (DOLCE) categories are thought of as cognitive artifacts, 
ultimately depending on human perception, cultural imprints and social 
conventions.[38,39] On the opposite side of the spectrum, a realist ontology aims at 
formalizing the real entities of the world, which we know through our best scientific 
theories.[40] In the biomedical domain, the OBO Foundry collection of interoperable 
ontologies is built upon the realist upper ontology BFO.[41,42] The medical domain is 
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seemingly a better fit for a cognitivist ontology, since it includes informational objects 
and mental constructs, such as diagnoses. However, these can also be efficiently 
formalized with a realist approach, as illustrated by the Ontology for General Medical 
Science (OGMS) [43], which formalizes a diagnosis as an informational content entity 
about the health status of a patient. 
 
CDIM was designed as a realist ontology and uses Basic Formal Ontology (BFO) 1.1 as 
the foundational ontology [44], based on BFO’s central role in the OBO Foundry. Several 
OBO Foundry ontologies, including OGMS, the Vital Sign Ontology (VSO) and the 
Information Artifact Ontology (IAO) were directly imported into CDIM.[45,46] CDIM 
also integrates classes from other ontologies such as the Ontology for Biomedical 
Investigations (OBI) and the Gene Ontology (GO).[47,48]  
 
 
Results 
  
CDIM introduced over 100 new classes and several additional properties and axioms, 
which in combination with imported ontologies resulted in the total of 549 classes and 82 
properties. As CDIM is stored inside a LexEVS instance, all imports are merged into a 
single .owl file, created directly in Protégé through the Refactor/Merge ontologies tool, 
enabling easier load processing in the framework. 
 
Temporal aspects are rarely, if at all, covered in the existing ontologies that we imported. 
As these play a crucial role in defining clinical eligibility criteria, we created 25 new 
classes to express these concepts. Whenever possible, we relied on equivalent classes 
instead of using anonymous classes, in order to support operations not based on Semantic 
Web reasoning techniques. Equivalent classes provide URIs that are then used as 
mapping targets for the CDIM-DSM mapping models. Internal validity and consistency 
was checked using the semantic reasoner HermiT 1.3.8.[49] 
 
CDIM design also required addition of some axioms to imported classes. For example, a 
diagnostic process can take a long time before completion and production of a diagnosis. 
It is therefore important to identify the end of the process, in order to correctly attach 
temporal information to the resulting diagnosis. This temporal aspect is currently lacking 
in OGMS, therefore we added the following classes and axioms in CDIM: 
 The equivalent class diagnostic process conclusion instant defined as 
o “temporal_instant and (has temporal occupant some diagnostic process 
conclusion) 
 The class diagnostic process conclusion was created and defined as: 
o a subclass of the BFO process boundary class. 
o it also bears the axiom “occupies temporal region some diagnostic process 
conclusion instant”, linking it to the temporal information. 
 The  diagnostic process class was enriched by adding the axiom: 
o ends_with some diagnostic process conclusion to define its final sub-
process as diagnostic process conclusion. 
 
 Published version: http://methods.schattauer.de/en/contents/archivestandard/manuscript/21298.html 
CDIM was evaluated in terms of its capacity to support query definitions required by the 
three use cases in TRANSFoRm. The first one is an epidemiological study on genetic risk 
markers for response to treatment in diabetes mellitus type 2. The main question is “Are 
well selected single nucleotide polymorphisms (SNPs) in type 2 diabetic patients 
associated with variations in drug response to oral antidiabetics (Sulfonylureas)?”[50] 
The second use case is a randomized controlled trial investigating on-demand vs. 
continuous use of proton pump inhibitors (PPIs) in treating gastroesophageal reflux 
disease (GORD) and its impact on symptom relief and quality of life in patients.[51] 
Finally, the third use case consists of evaluating approaches to provide diagnostic 
decision support, based on existing EHR data, reason for encounter and captured clinical 
clues. 
 
One of the major requirements for the first two use cases in TRANSFoRm is the ability to 
identify eligible patients in EHRs and other primary care data sources. Previous research 
found that two thirds of all information needed to assess the eligibility of a patient for a 
trial are related to disease history, namely disease, symptoms, signs and diagnostic or lab 
tests, and treatment history,[31] which also applies to the TRANSFoRm use cases. One 
of the crucial aspects is to minimize misclassification, while identifying eligible patients. 
As also found by the eMerge project, it is important to not solely rely on diagnostic codes 
to identify diagnoses, but to also use other patient characteristics like laboratory tests or 
medication to verify the diagnosis.[52–54] 
 
The data elements needed for these studies were described in detail by the project’s 
clinical researchers to ensure concepts coverage in CDIM. The main clinical concepts 
were: diagnoses (recent and medical history), laboratory tests, technical investigations 
(upper endoscopy), medications, symptoms and signs (difficulties swallowing, signs of 
gastrointestinal bleeding, unintentional weight loss), physical examination data (blood 
pressure, weight, height). The genetic concepts needed for the diabetes use case could be 
limited to SNPs. The following information also needed to be provided: moment of 
diagnosis; dates, values and units for all measurements; dates, number and dose for 
medication. 
 
For example, a formulated pharmaceutical can be characterized through several data item 
entities, including active ingredient data item, dose form data item and strength data 
item. Such formalization can be made compatible with pre-existing norms – for example, 
RxNorm’s category semantic clinical drug form could be formalized as the association of 
CDIM classes active ingredient data item and dose form data item.[55] Additionally, the 
instruction given by a prescription can be formalized as a subclass of OBI’s directive 
information entity, composed of several directive information entity parts. For example, 
the prescription “take Metformin 500 mg 3 times a day during two weeks” is composed 
of “3 times a day” (which is an instance of administration frequency item) and “during 
two weeks” (which is an instance of duration of treatment period item). 
 
Some items from the use cases have not been included in CDIM. These were the ones 
mostly focusing on habits (e.g., level of physical activity/sedentarism, dietary habits) or 
behavioral interventions (e.g., status of self-management education, or performance of 
 Published version: http://methods.schattauer.de/en/contents/archivestandard/manuscript/21298.html 
self-measurement of blood glucose). Although very important concepts, they were 
deemed too specific to a research area or very rarely encountered in current data sources. 
CDIM usage will be regularly reviewed to inform future classes additions and deletions.  
 
All concepts identified, as required by researchers, were successfully expressed in queries 
using CDIM and terminologies. We shall now present an example of how triplets using 
CDIM classes, operators and terminologies (or values) can be created and used in 
TRANSFoRm tools. 
 
Application to TRANSFoRm 
 
The TRANSFoRm Query Formulation Workbench provides a user interface for clinical 
researchers to create clinical studies, design eligibility criteria, initiate distributed queries, 
monitor query progress, and report query results. It captures eligibility criteria in a 
computable representation, which is based on CDIM ontology so the criteria can be 
translated into executable query statements on the data source side using CDIM to data 
source model mappings. They are then grouped to form application friendly reusable 
units. 
 
Let us consider an example inclusion criterion for patients who had an HbA1c test result 
of ≥ 6.5% on or before the 16/04/2013 date. The Laboratory Measurement group 
aggregates relevant concepts closely related to the laboratory test class extracted from 
CDIM, such as test type, date of test and test value. It is one of seven categories (like 
demographics, medications, etc.) currently used within the Workbench. The structure 
allows new categories to be easily added as per user requirements. 
 
 
 
Figure 3: Workbench criteria editor uses CDIM classes to create queries which can be 
applied to multiple primary care databases used by the TRANSFoRm project. 
 
The example criterion is specified by a user of the Query Formulation Workbench, as 
shown in Figure 3. The Laboratory Test artifact is presented to the user in the form of a 
template for entering values for operators and values. Resulting triplets would be: 
 laboratory_Test_Type_ID=[LOINC;4548-4] b 
 laboratory_measurement_datum ≥ 6.5 
                                                            
b Logical Observation Identifiers Names and Codes (LOINC) is a universal code system for identifying 
laboratory and clinical observations and the HbA1c test is represented by the code 4548-4 [56] 
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 laboratory_measurement_unit_label = [UO;0000187] c 
 lab_result_confirmation_instant ≤ 2013/04/16 
 
A query expressed in this way is passed to the data source, where a translation component 
uses CDIM (and its mappings to the local source model) to convert the query into a 
representation understandable by the local data source and extract results to send back to 
the researcher. 
 
Discussion 
 
TRANSFoRm is one of several complementary initiatives that develop services and tools 
to foster more efficient research using EHR data. Furthermore, only in aligning primary 
and secondary/tertiary care data can a full picture of patient’s clinical evolution be 
constructed. Therefore, facilitating interoperability between TRANSFoRm and other 
initiatives is essential. Using an ontology, as the core model, allows for formal logic to be 
used to define classes and their relationships, promoting a shared, well defined view of a 
domain. It is possible to reason about data elements present over multiple sources, and 
define new relationships.  
 
Specific classes, such as reason for health care encounter or health care episode, were 
designed in such a way as to avoid inconsistencies with other common classes. For 
example, a reason for health care encounter was formalized as an entity bearing a special 
role that we called the reason for health care encounter role. Thus, it was not necessary 
to modify the class diagnosis, symptom and sign in our ontology so that they could be a 
reason for health care encounter, as all these entities can bear the reason for health care 
encounter role. Therefore, the CDIM approach can reuse both existing terminologies 
(e.g., ICPC-2) and increasingly popular semantic web resources such as SPARQL 
repositories.[58] 
 
The reusability of CDIM is thereby enhanced since a large part of the specific 
requirements can be handled by the binding of terminologies providing sufficient 
precision and coverage for the desired context.[59] This facilitates ontology alignment 
and interoperability with other projects using ontologies, such as epSOS, that aims to 
develop a cross-border electronic health information transfer and also relies on BFO.[60]  
 
An additional benefit is that the necessary references to ontologies and terminologies can 
be created and embedded within existing standards, such as the CDISC Operational Data 
Model, which do not necessarily support ontologies, least of all the native creation of 
complex data elements constrained against both a clinical and research ontology.[61] 
Systems that support standards can thus be rapidly extended to support CDIM, without 
abandoning the existing standard. 
 
                                                            
c Units are represented as Ontology of Units of Measurements (UO). The unit for HbA1c is % (ratio), with 
UO code value 0000187 [57] 
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The CDIM ontology is by definition extensible, but the question arises as to what extent 
CDIM should be extended as new concepts are required, or leave this to the terminology. 
It is to be expected that not every single point, possibly evaluated in a research project, 
will make its way in CDIM. Some niche concepts might never be included, in order to 
keep the ontology manageable and relevant to most users. 
 
Nevertheless, extensively relying on terminologies does imply that the project has much 
less control on content and definition of concepts. For example, the ICPC-2 classifies 
diabetes as insulin dependent (T89) and non-insulin dependent (T90) diabetes. This has 
been revised and current approaches use mainly type-1 and type-2. Equivalences between 
these terms are not perfect as some type 2 “depend” on insulin for their treatment. 
However, this reflects the state of limitations for existing data. When an equivalence does 
exist between concepts, terminological heterogeneity can be mended by using inter-
terminology mappings like those offered by the UMLS.[62] 
 
Of note, the local-as-view mediation approach mandates that the decision to include a 
concept or not must be based on relevance to the users and not to its availability (or not) 
in data sources: a concept useful for many queries will be included even if no current data 
source contains it. In this context, a high number of queries using a concept but returning 
no data is highly informative. As incentives are put in place to foster the use of EHRs, 
such information might help focus such incentives in terms of research priorities. 
 
TRANSFoRm uses data and process provenance, as a means to achieve traceability and 
auditability in its digital infrastructure. The novelty of the TRANSFoRm provenance 
framework is that it links the provenance model, represented with the Open Provenance 
Model standard, to the medical domain models, by means of bridging ontologies, thereby 
enabling verification with respect to established concepts.[63] CDIM is a key element in 
this approach, since it allows a uniform conceptualization of annotations in provenance 
traces that are produced by multiple tools and across national boundaries. This has direct 
impact on the ability of the system to be audited in a consistent manner regardless of its 
geographical location, e.g., a clinical trial design conducted in Germany, or a record of 
data extraction for an epidemiological study in France. 
 
Genetic (and eventually proteomic and metabolic) primary observations will be more 
easily leveraged with time and as their availability increases. At some point, sequence 
structural variations and mutations, as well as, gene expression data will be relevant to 
the researcher and such concepts will also need to be included in CDIM. Nevertheless it 
is unclear, given the high heterogeneity inherent to the field of translational research, and 
the increasing use of genetic information in personalized medicine to which level of 
precision the models will need to abide by. 
 
Conclusion 
 
A unified mediation approach to semantic interoperability provides a flexible and highly 
extensible framework for interactions between health record systems and research 
systems. CDIM, as a core ontology of such an approach, enables simplicity and 
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consistency of design across the heterogeneous software landscape and can support the 
specific needs of EHR-driven phenotyping, using primary care data. This was 
demonstrated in TRANSFoRm, where the software tools such as the Query Workbench 
are agnostic of the structural and terminological details of the data sources they interact 
with.  
 
CDIM is flexible and modular by design as it can be bound to multiple terminologies, 
enabling new ways to approach data as the requirements of translational medicine evolve 
and new domains like epigenetic become part of patient care.  
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